hMSC-derived extracellular vesicles production in the scale-X™ hydro fixed-bed bioreactor
Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms
Learn moreProof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms
Learn moreAchieve 3-fold increase in AAV-2 cell-specific productivity using a suspension HEK293F cell line in the scale-X™ structured fixed-bed bioreactor
Learn moreImplementation of a metabolite-based cell density estimation and evaluation of harvest strategies for Lentivirus production with HEK293T cells
Learn moreAchievement of large-scale, cost-efficient enzymatic cell collection from structured fixed-bed bioreactors to facilitate and de-risk seed train generation
Learn moreStatic cell cultivation and production process transferred to the scale-X™ hydro bioreactor.
Learn moreShake flask process transferred in a scale-X hydro fixed-bed bioreactor for Adenovirus production with HEK293 cells adapted to suspension.
Learn moreProcess optimization and scale-up from static flask to scale-X bioreactor with 30 m² cell growth surface.
Learn moreDirect process reproduction from multi-layer bioreactor and roller bottles for four vaccine antigens using three different cell lines (CEF, WI-38 and Vero cells)
Learn moreCase study comparing adherent Vero cell growth on microcarriers and intensified, fixed-bed scale-X bioreactors hydro (2.4 m²) and carbo (10-30 m²). Results demonstrate the scale-X bioreactors as a suitable alternative to traditional technologies.
Learn moreProof of concept for scalable adherent cell growth and adenovirus production
Learn more